Skip to main content
. 2020 Jul;9(7):4111–4120. doi: 10.21037/tcr-20-1451

Table 3. Clinical response according to LMR-week 6 for 121 patients.

Response Number (N=121, %) Low LMR-week 6 (N=66, 54.5%) High LMR-week 6 (N=55, 45.5%)
CR 8 (6.6) 1 (1.5) 7 (12.7)
PR 15 (12.4) 4 (6.1) 11 (20.0)
SD 34 (28.1) 22 (33.3) 12 (21.8)
PD 64 (52.9) 39 (59.1) 25 (45.5)

N, number; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; LMR-week 6, lymphocyte-to-monocyte ratio 6 weeks after the start of PD-1 inhibitors.